These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26012143)

  • 21. How to achieve optimal correction of acidosis in end-stage renal failure patients.
    Zucchelli P; Santoro A
    Blood Purif; 1995; 13(6):375-84. PubMed ID: 8821203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of different buffers on the biocompatibility of CAPD solutions.
    Schambye HT
    Perit Dial Int; 1996; 16 Suppl 1():S130-6. PubMed ID: 8728179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-lactate for high-efficiency hemodialysis: feasibility studies and a randomized comparison with acetate and bicarbonate.
    Dalal SP; Ajam M; Gupta DK; Gupta R; Nawab Z; Manahan FJ; Ing TS; Daugirdas JT
    Int J Artif Organs; 1989 Oct; 12(10):611-7. PubMed ID: 2680995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis-Related Acidemia and Acidosis by Dialysate: The Forgotten Issue of CO2 Overload from Dialysate.
    Marano M; Borrelli S; Zamboli P
    Blood Purif; 2016; 41(4):313-4. PubMed ID: 26848987
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
    le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
    Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Bicarbonate Slows Decline of Residual Renal Function in Peritoneal Dialysis Patients.
    Liu XY; Gao XM; Zhang N; Chen R; Wu F; Tao XC; Li CJ; Zhang P; Yu P
    Kidney Blood Press Res; 2017; 42(3):565-574. PubMed ID: 29032379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of bicarbonate/lactate-buffered dialysate with a nighttime cycler, associated with a daytime dwell with icodextrin, may result in alkalosis in children.
    Vande Walle JG; Raes AM; Dehoorne J; Mauel R
    Adv Perit Dial; 2004; 20():222-5. PubMed ID: 15384831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peritoneal dialysis solutions].
    Montenegro J
    Nefrologia; 2008; 28 Suppl 5():59-65. PubMed ID: 18847422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid-base balance on peritoneal dialysis.
    La Greca G; Biasioli S; Chiaramonte S; Davi M; Fabris A; Feriani M; Pisani E; Ronco C; Zen F
    Clin Nephrol; 1981 Jul; 16(1):1-7. PubMed ID: 7273491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.
    Pajek J; Kveder R; Bren A; Gucek A; Bucar M; Skoberne A; Waniewski J; Lindholm B
    Nephrol Dial Transplant; 2009 May; 24(5):1617-25. PubMed ID: 19066345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do bicarbonate-based solutions for continuous renal replacement therapy offer better control of metabolic acidosis than lactate-containing fluids?
    Agarwal B; Kovari F; Saha R; Shaw S; Davenport A
    Nephron Clin Pract; 2011; 118(4):c392-8. PubMed ID: 21346374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METABOLIC ACIDOSIS--AN UNDERESTIMATED PROBLEM AFTER KIDNEY TRANSPLANTATION?
    Katalinić L; Blaslov K; Đanić-Hadžibegović A; Gellineo L; Kes P; Jelaković B; Basić-Jukić N
    Acta Clin Croat; 2015 Dec; 54(4):486-91. PubMed ID: 27017724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic acidosis in peritoneal dialysis patients: the role of residual renal function.
    Tian XK; Shan YS; Zhe XW; Cheng LT; Wang T
    Blood Purif; 2005; 23(6):459-65. PubMed ID: 16244471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with a 39 mmol/L bicarbonate-buffered peritoneal dialysis solution.
    Feriani M; Carobi C; La Greca G; Buoncristiani U; Passlick-Deetjen J
    Perit Dial Int; 1997; 17(1):17-21. PubMed ID: 9068017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short term study on relative merits of acetate and bicarbonate dialysis.
    Gurudev KC; Pathak V; Prabhakar KS; Bhaskar S; Prakash KC; Prabhakaran ; Mani MK
    J Assoc Physicians India; 1991 Dec; 39(12):921-4. PubMed ID: 1816218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal dialysate bicarbonate during hemodialysis.
    Rault R
    ASAIO Trans; 1991; 37(3):M372-3. PubMed ID: 1751193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Con: Higher serum bicarbonate in dialysis patients is protective.
    Chauveau P; Rigothier C; Combe C
    Nephrol Dial Transplant; 2016 Aug; 31(8):1226-9. PubMed ID: 27411724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acid-base balance in haemodialyzed patients].
    Hrabcáková P; Mydlík M; Molcányiová A
    Vnitr Lek; 2002 Oct; 48(10):959-61. PubMed ID: 16737145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.